|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 270.37 USD | -0.68% |
|
+0.38% | -23.14% |
| 07:54pm | Markets Wanted a Party. The Economy Brought a Reality Check. |  |
| 07:29pm | Accenture Invests in Healthcare Technology Firm Ryght AI to Accelerate Drug Development | MT |
| Capitalization | 17TCr 14TCr 13TCr 13TCr 23TCr 15,22700Cr 25TCr 1,56200Cr 61TCr 7,19300Cr 63TCr 62TCr 26,21000Cr | P/E ratio 2026 * |
20.2x | P/E ratio 2027 * | 18.4x |
|---|---|---|---|---|---|
| Enterprise value | 16TCr 14TCr 13TCr 12TCr 22TCr 14,38300Cr 24TCr 1,47600Cr 57TCr 6,79500Cr 60TCr 59TCr 24,75800Cr | EV / Sales 2026 * |
2.17x | EV / Sales 2027 * | 2.01x |
| Free-Float |
92.79% | Yield 2026 * |
2.4% | Yield 2027 * | 2.62% |
Last Transcript: Accenture plc
| 1 day | -0.37% | ||
| 1 week | +0.73% | ||
| Current month | +8.52% | ||
| 1 month | +11.85% | ||
| 3 months | +11.12% | ||
| 6 months | -15.01% | ||
| Current year | -22.88% |
| 1 week | 265.01 |  | 277.65 |
| 1 month | 237.43 | | 280.71 |
| Current year | 229.4 | | 398.35 |
| 1 year | 229.4 | | 398.35 |
| 3 years | 229.4 | | 398.35 |
| 5 years | 229.4 | | 417.37 |
| 10 years | 91.4 | | 417.37 |
| Manager | Title | Age | Since |
|---|---|---|---|
Julie Sweet
CEO | Chief Executive Officer | 58 | 01/09/2019 |
Angie Park
DFI | Director of Finance/CFO | - | 01/12/2024 |
Penelope Prett
CTO | Chief Tech/Sci/R&D Officer | - | 01/12/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Julie Sweet
CHM | Chairman | 58 | 01/09/2021 |
| Director/Board Member | 70 | 20/08/2013 | |
Paula Price
BRD | Director/Board Member | 63 | 09/05/2014 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 7.6% | 26 M€ | +11.07% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.36% | +0.73% | -25.43% | -7.20% | 17TCr | |
| -0.88% | +0.78% | +34.89% | +108.03% | 29TCr | |
| +0.08% | +0.37% | -27.99% | -3.06% | 13TCr | |
| +1.79% | +1.75% | -12.24% | -0.19% | 10TCr | |
| +2.01% | -5.73% | +28.70% | +46.69% | 7.41TCr | |
| +0.83% | +1.22% | -17.99% | +1.83% | 7.31TCr | |
| -0.03% | -1.02% | -19.10% | +28.93% | 7.29TCr | |
| +0.38% | +1.94% | -13.63% | +62.76% | 5.01TCr | |
| -1.56% | -4.72% | +115.00% | +482.70% | 4.75TCr | |
| -1.00% | -1.19% | +45.00% | +119.52% | 4.63TCr | |
| Average | +0.11% | -1.70% | +10.72% | +84.00% | 10.58TCr | |
| Weighted average by Cap. | -0.02% | -0.47% | +6.91% | +63.56% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 7.36TCr 6.26TCr 5.84TCr 5.48TCr 10TCr 6,63700Cr 11TCr 68TCr 26TCr 3,13500Cr 28TCr 27TCr 11,42300Cr | 7.76TCr 6.6TCr 6.17TCr 5.78TCr 11TCr 7,00200Cr 12TCr 72TCr 28TCr 3,30800Cr 29TCr 29TCr 12,05200Cr |
| Net income | 844.89Cr 718.83Cr 671.12Cr 629.64Cr 1.16TCr 76TCr 1.27TCr 7.82TCr 3.04TCr 36TCr 3.17TCr 3.1TCr 1,31200Cr | 925.52Cr 787.43Cr 735.17Cr 689.72Cr 1.28TCr 83TCr 1.39TCr 8.57TCr 3.33TCr 39TCr 3.47TCr 3.4TCr 1,43700Cr |
| Net Debt | -935.26Cr -795.72Cr -742.9Cr -696.98Cr -1.29TCr -84TCr -1.4TCr -8.66TCr -3.36TCr -40TCr -3.51TCr -3.44TCr -1,45200Cr | -1.25TCr -1.06TCr -991.64Cr -930.35Cr -1.72TCr -1,12600Cr -1.87TCr -12TCr -4.49TCr -53TCr -4.68TCr -4.59TCr -1,93800Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/25/12 | 270.37 $ | -0.68% | 40,59,793 |
| 10/25/10 | 272.22 $ | +1.00% | 35,80,740 |
| 09/25/09 | 269.53 $ | +1.14% | 35,15,049 |
| 08/25/08 | 266.50 $ | -0.03% | 32,18,875 |
| 05/25/05 | 266.59 $ | -1.02% | 37,85,500 |
Delayed Quote Nyse, December 12, 2025 at 01:10 am IST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ACN Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition